CHICAGO, IL—GLS Capital, one of the world’s largest private investment firms focused on litigation finance, announced that firm co-founders and Managing Directors Adam Gill and Jamison Lynch, and firm Principal Joel Merkin have been recognized in the 2024 edition of IAM Strategy 300: The World’s Leading IP Strategists.
Gill has evaluated thousands of patent opportunities, which he leads for GLS Capital, and has underwritten and managed hundreds of millions of dollars of litigation finance investments.
Lynch leads GLS Capital’s investments in life sciences and special situations, including matters involving product development, regulatory approval and litigation regarding medical devices, pharmaceutical products, health care, and other life sciences matters.
A registered patent attorney, Merkin is responsible for due diligence and monitoring of patent investments for GLS Capital. He uses his patent litigation experience and engineering background to evaluate patent opportunities, particularly in the high-tech space.
The post GLS Capital Principals Recognized in 2024 IAM Strategy 300 appeared first on Attorney at Law Magazine.